All In Biotech

Drug Trial Radar · NCT07088068

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

A Randomized, Double-blind, Phase 3 Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Recently Diagnosed Stage 3 Type 1 Diabetes (T1D)

Last checked: Nov 19, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 723 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

723

Planned (sponsor's estimate)

Start

Aug 6, 2025

Primary completion

Jun 6, 2028

Study completion Dec 12, 2028

Sponsor

Lead sponsor
SanofiSanofi (SNY)
Sponsor type
Industry
First posted
Jul 28, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 1 year, up to 25 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, randomized, double-blind, parallel, placebo-controlled Phase 3, 2-arm study for treatment. The purpose of this study is to measure change in glycemic control and prandial insulin independency over 52 weeks with teplizumab compared with placebo, both administered by intravenous (IV) infusion, in participants with recently diagnosed Stage 3 type 1 diabetes (T1D) aged 1 to 25 years, on standard insulin therapy.

Conditions

  • Type 1 Diabetes Mellitus

Interventions

  • TeplizumabDrug

    Pharmaceutical form: Concentrated solution for infusion Route of administration: Intravenous infusion

  • PlaceboOther

    Pharmaceutical form: Concentrated solution for infusion Route of administration: Intravenous infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. For United States (US) and non-European Union (EU) countries: Glycated hemoglobin (HbA1c) change from baselineTime frame: From Baseline to Week 52
  2. For US and non-EU countries: Total number of days without prandial insulin useTime frame: From baseline to Week 52
  3. For EU countries: Change from baseline in mean 2 hours mixed meal tolerance test (MMTT) stimulated C-peptide concentration, calculated from Area Under the Curve (AUC) in participants 5 years and olderTime frame: From baseline to Week 52
  4. For EU countries: HbA1c change from baselineTime frame: From baseline to Week 52
  5. For EU countries: Total number of days without prandial insulin useTime frame: From baseline to Week 52

Locations

201 sites in 20 countries. Site status is shown where the registry gives one.

  • Scottsdale Clinical Trials- Site Number : 8400044

    Scottsdale, Arizona · Recruiting

  • Rady Children's Hospital- Site Number : 8400002

    San Diego, California · Recruiting

  • University of California San Francisco - Mission Bay- Site Number : 8400011

    San Francisco, California · Recruiting

  • Barbara Davis Center for Childhood Diabetes- Site Number : 8400031

    Aurora, Colorado · Recruiting

  • Yale University School of Medicine- Site Number : 8400005

    New Haven, Connecticut · Recruiting

  • University of Florida College of Medicine- Site Number : 8400054

    Gainesville, Florida · Recruiting

  • Encore Medical Research - Hollywood- Site Number : 8400061

    Hollywood, Florida · Recruiting

  • Nemours Children's Speciality Care- Jacksonville- Site Number : 8400040

    Jacksonville, Florida · Recruiting

  • University of South Florida- Site Number : 8400013

    Tampa, Florida · Recruiting

  • AdventHealth Winter Park- Site Number : 8400033

    Winter Park, Florida · Recruiting

  • Atlanta Diabetes Associates- Site Number : 8400036

    Atlanta, Georgia · Recruiting

  • Children's Healthcare of Atlanta - Egleston Hospital- Site Number : 8400065

    Atlanta, Georgia · Recruiting

  • IACT Health - Columbus - Talbotton Road- Site Number : 8400003

    Columbus, Georgia · Recruiting

  • St. Luke's Children's Hospital- Site Number : 8400014

    Boise, Idaho · Recruiting

  • Rocky Mountain Clinical Research - Idaho Falls- Site Number : 8400001

    Idaho Falls, Idaho · Recruiting

  • Norton Children's Research Institute - Wendy Novak Diabetes Institute- Site Number : 8400016

    Louisville, Kentucky · Recruiting

  • C.S. Mott Children's Hospital- Site Number : 8400015

    Ann Arbor, Michigan · Recruiting

  • Mayo Clinic in Rochester - Minnesota- Site Number : 8400019

    Rochester, Minnesota · Recruiting

  • Park Nicollet Institute - Oncology Research- Site Number : 8400059

    Saint Louis Park, Minnesota · Recruiting

  • Children's Mercy Adelle Hall Campus- Site Number : 8400010

    Kansas City, Missouri · Recruiting

  • University At Buffalo - Jacobs School Of Medicine- Site Number : 8400006

    Buffalo, New York · Recruiting

  • Endocrine Associates of West Village- Site Number : 8400064

    New York, New York · Recruiting

  • Columbia University Irving Medical Center- Site Number : 8400009

    New York, New York · Recruiting

  • Asheville Clinical Research- Site Number : 8400045

    Asheville, North Carolina · Recruiting

  • UNC Children's Hospital- Site Number : 8400034

    Chapel Hill, North Carolina · Recruiting

  • Cincinnati Children's Hospital Medical Center- Site Number : 8400018

    Cincinnati, Ohio · Recruiting

  • The Ohio State University- Site Number : 8400051

    Columbus, Ohio · Recruiting

  • The Children's Hospital of Philadelphia- Site Number : 8400039

    Philadelphia, Pennsylvania · Recruiting

  • AM Diabetes & Endocrinology Center- Site Number : 8400004

    Bartlett, Tennessee · Recruiting

  • Baylor College of Medicine- Site Number : 8400057

    Houston, Texas · Recruiting

  • University of Utah Health Hospital- Site Number : 8400052

    Salt Lake City, Utah · Recruiting

  • Uva Children's Battle Building- Site Number : 8400060

    Charlottesville, Virginia · Recruiting

  • Benaroya Research Institute at Virginia Mason- Site Number : 8400038

    Seattle, Washington · Recruiting

  • MultiCare Mary Bridge Children's Health Center- Site Number : 8400037

    Tacoma, Washington · Recruiting

  • Investigational Site Number : 0320005

    Buenos Aires, Argentina · Recruiting

  • Investigational Site Number : 0320013

    Córdoba, Argentina · Recruiting

  • Investigational Site Number : 0320002

    Salta, Argentina · Recruiting

  • Investigational Site Number : 0320012

    Santa Fe, Argentina · Recruiting

  • Investigational Site Number : 0320008

    Mar del Plata, Buenos Aires, Argentina · Recruiting

  • Investigational Site Number : 0320003

    San Miguel de Tucumán, Tucumán Province, Argentina · Recruiting

Showing 40 of 201 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.